The Hindu : Business : Wockhardt in licensing deal with U.K. company

Online edition of India's National Newspaper
Friday, Oct 10, 2008
ePaper | Mobile/PDA Version

Business

Business

Wockhardt in licensing deal with U.K. company

Special Correspondent

To sell dermatology, dental products

Will leverage technological capabilities
In talks with Sinclair on contract manufacturing

MUMBAI: Wockhardt has entered into an in-licensing agreement with Sinclair Pharma of the U.K. to market a range of dermatology and dental products. Sinclair is an international speciality pharmaceutical company with subsidiaries in France, Italy, Spain, and Portugal with operations spanning across 82 countries.

“As part of our India business strategy, in-licensing is seen as one of our key growth drivers. These in-licensing deals will fulfil our aim of getting niche global products for the benefit of our Indian patients,” said Wockhardt Chairman Habil Khorakiwala. “We bring to India breakthrough products that have proved their effectiveness in Europe and USA and also strengthen our existing portfolios,” he further added.

As per the agreement, Wockhardt will leverage its technological capabilities by making the formulations in India from bulk imported from Sinclair Pharma. Wockhardt is also in talks with Sinclair on contract manufacturing of the signed products for their European markets and to bring in to India the next phase of dermatology products from the Sinclair stable.

This agreement is a further step towards Wockhardt’s strategy of consolidating its position in dermatology and focus in dentistry. The ten-year exclusive agreement covers a range of patented and innovative products like Papulex, an innovative formulation for acne, Atopiclair, a non steroidal cream for atopic dermatitis, Aloclair, a patented gel for mouth ulcer and Decapinol range, a patented formulation for the treatment of Gingivitis and plaque.

Printer friendly page
Send this article to Friends by E-Mail

Business